VORICONAZOLE AS SALVAGE THERAPY IN IMMUNOCOMPROMISED PATIENTS WITH PULMONARY ASPERGILLOSIS WHO RECEIVED FIRST LINEE ANTIFUNGAL THERAPY WITH CASPOFUNGIN

被引：0
|
作者：
Simeone, E. [1 ]
Candoni, A. [1 ]
Chiozzotto, M. [1 ]
Fanin, R. [1 ]
机构：
[1] Div Hematol, Udine, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0179
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [41] Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin
    I I Raad
    H A Hanna
    M Boktour
    Y Jiang
    H A Torres
    C Afif
    D P Kontoyiannis
    R Y Hachem
    Leukemia, 2008, 22 : 496 - 503
  • [42] Combination Antifungal Therapy for Invasive Pulmonary Aspergillosis in a Heart Transplant Recipient
    Beiras-Fernandez, Andres
    Bigdeli, Amir K.
    Nickel, Thomas
    Michel, Sebastian
    Ueberfuhr, Peter
    Reichart, Bruno
    Kaczmarek, Ingo
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (04) : 279 - 283
  • [43] The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib
    Nyga, Remy
    Simon, Laura
    Chouaki, Taieb
    Delette, Caroline
    Bennis, Youssef
    Joseph, Cedric
    Marolleau, Jean-Pierre
    Slama, Michel
    Zogheib, Elie
    Maizel, Julien
    CRITICAL CARE, 2019, 23
  • [44] Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin
    Raad, I. I.
    Hanna, H. A.
    Boktour, M.
    Jiang, Y.
    Torres, H. A.
    Afif, C.
    Kontoyiannis, D. P.
    Hachem, R. Y.
    LEUKEMIA, 2008, 22 (03) : 496 - 503
  • [45] The evolution of invasive pulmonary aspergillosis on chest imaging in response to antifungal therapy
    Chong, Woon H.
    Ibrahim, Ammoura
    Saha, Biplab Kumar
    BMJ CASE REPORTS, 2021, 14 (03)
  • [46] Experiences with caspofungin plus posaconazole in immunocompromised adults with invasive aspergillosis (IA) refractory to prior standard therapy.
    Dahike, Joachim
    Zabelina, Tatjana
    Lellek, Heinrich
    Muth, Alexander
    Waschke, Olga
    Wolschke, Christine
    Sobottka, Ingo
    Kroeger, Nicolaus
    Zander, Axel R.
    BLOOD, 2006, 108 (11) : 411B - 411B
  • [47] PRIMARY HYPERPARATHYROIDISM IN PATIENTS WHO HAVE, RECEIVED RADIATION-THERAPY AND IN PATIENTS WHO HAVE, NOT RECEIVED RADIATION-THERAPY
    TEZELMAN, S
    RODRIGUEZ, JM
    SHEN, W
    SIPERSTEIN, AE
    DUH, QY
    CLARK, OH
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1995, 180 (01) : 81 - 87
  • [48] Caspofungin plus posaconazole in patients after allogeneic stem cell transplantation with invasive aspergillosis refractory to prior standard antifungal therapy
    Dahlke, J.
    Zabelina, T.
    Lellek, H.
    Muth, A.
    Waschke, O.
    Wolschke, C.
    Sobottka, I.
    Kroger, N.
    Zander, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S286 - S287
  • [49] Influenza and prophylactic antifungal therapy for aspergillosis: addressing some questions first
    Coste, Anne
    De Longeaux, Kahaia
    Aubron, Cecile
    INTENSIVE CARE MEDICINE, 2021, 47 (11) : 1341 - 1342
  • [50] Influenza and prophylactic antifungal therapy for aspergillosis: addressing some questions first
    Anne Coste
    Kahaia De Longeaux
    Cécile Aubron
    Intensive Care Medicine, 2021, 47 : 1341 - 1342
12345